
| Salt Composition: | Glimepiride (2mg) + Metformin (1000mg) |
| Manufacturer: | Serwina Pharmaceuticals Private Limited |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Metormi-G2 D Tablet SR is an anti-diabetic drug used to treat type 2 diabetes mellitus in adults by controlling blood sugar levels. Metormi-G2 D Tablet SR is a combination of two medicines, Glimepiride and Metformin, used to manage type 2 diabetes mellitus in adults. Glimepiride increases insulin release from the pancreas, while Metformin reduces glucose production in the liver, delays glucose absorption from the intestines, and enhances insulin sensitivity. This combination helps in better control of blood sugar levels. However, it may cause side effects like hypoglycemia, especially when used with other antidiabetic medicines or alcohol. It is important to monitor blood sugar levels regularly and inform your doctor about any unusual symptoms. The medicine may not be safe during pregnancy and breastfeeding, and alcohol consumption should be avoided.
Metormi-G2 D Tablet SR is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride increases the amount of insulin released by the pancreas to lower blood glucose. Metformin lowers glucose production in the liver, delays glucose absorption from the intestines, and increases the body's sensitivity to insulin.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Metormi-G2 D Tablet SR is to be taken with food.
Alcohol
It is unsafe to consume alcohol with Metormi-G2 D Tablet SR.
Breastfeed
Metormi-G2 D Tablet SR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnancy
Metormi-G2 D Tablet SR may be unsafe to use during pregnancy. Consult your doctor for advice.